1. Home
  2. TCPC vs SIBN Comparison

TCPC vs SIBN Comparison

Compare TCPC & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCPC
  • SIBN
  • Stock Information
  • Founded
  • TCPC 2006
  • SIBN 2008
  • Country
  • TCPC United States
  • SIBN United States
  • Employees
  • TCPC N/A
  • SIBN N/A
  • Industry
  • TCPC Finance/Investors Services
  • SIBN Medical/Dental Instruments
  • Sector
  • TCPC Finance
  • SIBN Health Care
  • Exchange
  • TCPC Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • TCPC 603.8M
  • SIBN 606.1M
  • IPO Year
  • TCPC 2012
  • SIBN 2018
  • Fundamental
  • Price
  • TCPC $5.83
  • SIBN $15.10
  • Analyst Decision
  • TCPC Sell
  • SIBN Strong Buy
  • Analyst Count
  • TCPC 2
  • SIBN 4
  • Target Price
  • TCPC $6.75
  • SIBN $25.75
  • AVG Volume (30 Days)
  • TCPC 850.1K
  • SIBN 455.8K
  • Earning Date
  • TCPC 11-05-2025
  • SIBN 11-11-2025
  • Dividend Yield
  • TCPC 20.89%
  • SIBN N/A
  • EPS Growth
  • TCPC N/A
  • SIBN N/A
  • EPS
  • TCPC N/A
  • SIBN N/A
  • Revenue
  • TCPC $239,535,768.00
  • SIBN $185,262,000.00
  • Revenue This Year
  • TCPC N/A
  • SIBN $19.96
  • Revenue Next Year
  • TCPC N/A
  • SIBN $16.24
  • P/E Ratio
  • TCPC N/A
  • SIBN N/A
  • Revenue Growth
  • TCPC 3.11
  • SIBN 22.93
  • 52 Week Low
  • TCPC $5.82
  • SIBN $11.70
  • 52 Week High
  • TCPC $9.72
  • SIBN $20.05
  • Technical
  • Relative Strength Index (RSI)
  • TCPC 21.24
  • SIBN 50.88
  • Support Level
  • TCPC $6.03
  • SIBN $14.20
  • Resistance Level
  • TCPC $6.17
  • SIBN $14.76
  • Average True Range (ATR)
  • TCPC 0.15
  • SIBN 0.54
  • MACD
  • TCPC -0.04
  • SIBN 0.09
  • Stochastic Oscillator
  • TCPC 0.00
  • SIBN 91.64

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: